Trial Profile
Effects of telmisartan and carvedilol in South Korean patients with hypertension and metabolic syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Carvedilol
- Indications Hypertension; Metabolic syndrome
- Focus Therapeutic Use
- 14 Nov 2012 New trial record
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.